This framework offers a powerful translational platform: while receptor mutations in canines illuminated the molecular basis of state fragmentation, recent human studies implicate immune-mediated loss of orexin neurons in narcolepsy type 1, with genetic and environmental factors modulating vulnerability [9,11]. The gene discussed is HCRT; the disease is narcolepsy-cataplexy syndrome.